10 recruiting. 10 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Recruiting 10 |
Follow Encephalitis: new trials by email Literature Review of Encephalitis trials Research Report on Encephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efgartigimod in Anti-NMDA Receptor Encephalitis. Efgartigimod Alfa - Encephalitis Autoimmune | Phase 2 | Recruiting | Beijing Tongren Hospital | 20 | 2026-06-25 | 2026-09-16 |
| Intravenous Brincidofovir as an Antiviral for Treatment of Progressive Multifocal Leukoencephalopathy: A Pilot Study Brincidofovir - Progressive Multifocal Leukoencephalopathy | Phase 2 | Recruiting | National Institute of Neurological Disorders and Stroke (NINDS) | 24 | 2026-06-05 | 2026-07-22 |
| A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease ART5803, ART5803-Cohort D - Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE), Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric Disease | Phase 2 | Recruiting | Arialys Australia Pty Ltd | 30 | 2026-05-15 | 2026-10-27 |
| T-cell Therapy in Patients With PML Application of T-lymphocytes - Progressive Multifocal Leucoencephalopathy (PML) | Phase 2 | Recruiting | Hannover Medical School | 23 | 2026-02-06 | 2026-10-15 |
| Adjunctive Doxycycline for Central Nervous System Tuberculosis Doxycycline, Placebo, Anti Tuberculosis Drug - Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology) | Phase 2 | Recruiting | National University Hospital, Singapore | 200 | 2025-08-21 | 2026-06-01 |
| High-Titer Neutralizing Plasma for West Nile Fever in Hospitalized Patients Plasma - West Nile Fever | Phase 2 | Recruiting | Gili Regev-Yochay MD | 37 | 2025-07-30 | 2025-08-26 |
| Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis Taitacept - Anti-N-Methyl-D-Aspartate Receptor Encephalitis | Phase 2 | Recruiting | Beijing Tongren Hospital | 10 | 2024-12-01 | 2024-11-20 |
| The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis Inebilizumab, Placebo - Autoimmune Encephalitis, Encephalitis | Phase 2 | Recruiting | University of Utah | 116 | 2022-03-30 | 2025-07-01 |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis Bortezomib, Placebo - Autoimmune Encephalitis | Phase 2 | Recruiting | Jena University Hospital | 50 | 2020-05-13 | 2025-09-04 |
| Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus Allogeneic BK-specific Cytotoxic T-lymphocytes, Laboratory Biomarker Analysis - Acquired Immunodeficiency Syndrome, BK Virus Infection | Phase 2 | Recruiting | M.D. Anderson Cancer Center | 100 | 2015-07-23 | 2026-09-04 |
Autoimmune Diseases of the Nervous System (4) · Anti-N-Methyl-D-Aspartate Receptor Encephalitis (2) · Leukoencephalopathy, Progressive Multifocal (2) · Acquired Immunodeficiency Syndrome (1) · Autoimmune Diseases (1) · Carcinoma, Merkel Cell (1) · Encephalitis, Viral (1) · Meningitis (1) · Meningoencephalitis (1) · Neoplasms (1) · Rare Diseases (1) · Tuberculosis (1) · Tuberculosis, Central Nervous System (1) · Tuberculosis, Meningeal (1)
Brain Diseases (10) · Central Nervous System Diseases (10) · Nervous System Diseases (10) · Neuroinflammatory Diseases (10) · Immune System Diseases (6) · Central Nervous System Infections (5) · Central Nervous System Viral Diseases (5) · Infections (5) · Autoimmune Diseases (4) · Infectious Encephalitis (4) · Virus Diseases (4) · DNA Virus Infections (3) · Encephalitis, Viral (3) · Polyomavirus Infections (3)
Antitubercular Agents (1) · Bortezomib (1) · Doxycycline (1) · brincidofovir (1) · efgartigimod alfa (1) · inebilizumab (1)
Beijing Tongren Hospital (2) · Arialys Australia Pty Ltd (1) · Gili Regev-Yochay MD (1) · Hannover Medical School (1) · Jena University Hospital (1) · M.D. Anderson Cancer Center (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National University Hospital, Singapore (1) · University of Utah (1)
United States (3) · China (2) · Germany (2) · Indonesia (1) · Israel (1) · Malaysia (1) · Netherlands (1) · Singapore (1) · South Korea (1) · Spain (1)
Christian Geis, Prof. (1) · George Chen, MD (1) · Gili Regev-Yochay, MD (1) · Irene CM Cortese, M.D. (1) · Jiawei Wang (1) · Pete Flynn, PhD (1) · Stacey L Clardy, MD, PhD (1)
PMID 11113214, PMID 12393404, PMID 15564716, PMID 15817019, PMID 17262855, PMID 17538176, PMID 18417336, PMID 18851928, PMID 19680671, PMID 20427647, PMID 20605905, PMID 20829370, PMID 21163445, PMID 21865579, PMID 23151040, PMID 23290630, PMID 24360484, PMID 24763533, PMID 25392198, PMID 25573986, PMID 26187412, PMID 27267753, PMID 27399303, PMID 27412413, PMID 27575749, PMID 27886126, PMID 29143550, PMID 29159189, PMID 29293273, PMID 29406578, PMID 29476014, PMID 29549218, PMID 29956883, PMID 30304652, PMID 30578370, PMID 30675918, PMID 31292262, PMID 31495497, PMID 31900318, PMID 32052483, PMID 32641101, PMID 33929874, PMID 42402341
2019 (1)